These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 31021241)
1. Safe Harbor Targeted CRISPR-Cas9 Tools for Molecular-Genetic Imaging of Cells in Living Subjects. Dubois VP; Zotova D; Parkins KM; Swick C; Hamilton AM; Kelly JJ; Ronald JA CRISPR J; 2018 Dec; 1():440-449. PubMed ID: 31021241 [TBL] [Abstract][Full Text] [Related]
2. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C F1000Res; 2019; 8():1911. PubMed ID: 32789000 [No Abstract] [Full Text] [Related]
3. Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9. Ma X; Cao R; Xiao H; Cao Z Oncol Lett; 2020 Dec; 20(6):354. PubMed ID: 33123265 [TBL] [Abstract][Full Text] [Related]
4. Safe harbor-targeted CRISPR-Cas9 homology-independent targeted integration for multimodality reporter gene-based cell tracking. Kelly JJ; Saee-Marand M; Nyström NN; Evans MM; Chen Y; Martinez FM; Hamilton AM; Ronald JA Sci Adv; 2021 Jan; 7(4):. PubMed ID: 33523917 [TBL] [Abstract][Full Text] [Related]
5. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575 [TBL] [Abstract][Full Text] [Related]
6. Determining On-Target, Off-Target, and Copy Number Status of Transgenic Events After CRISPR/Cas9 Targeted AAVS1 Safe-Harbor Modification of iPSCs Using Double-Control Quantitative Copy Number PCR. Schjeide BM; Püschel GP Curr Protoc; 2023 Jan; 3(1):e635. PubMed ID: 36598341 [TBL] [Abstract][Full Text] [Related]
7. Artificial MicroRNAs as Novel Secreted Reporters for Cell Monitoring in Living Subjects. Ronald JA; D'Souza AL; Chuang HY; Gambhir SS PLoS One; 2016; 11(7):e0159369. PubMed ID: 27442530 [TBL] [Abstract][Full Text] [Related]
8. Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation. Inderbitzin A; Loosli T; Kouyos RD; Metzner KJ Mol Ther Methods Clin Dev; 2022 Sep; 26():107-118. PubMed ID: 35795775 [TBL] [Abstract][Full Text] [Related]
9. Cloning of human Vats N; Sanal MG; Venugopal SK; Taneja P; Sarin SK F1000Res; 2020; 9():1498. PubMed ID: 33868646 [No Abstract] [Full Text] [Related]
10. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction. Neyrinck K; Breuls N; Holvoet B; Oosterlinck W; Wolfs E; Vanbilloen H; Gheysens O; Duelen R; Gsell W; Lambrichts I; Himmelreich U; Verfaillie CM; Sampaolesi M; Deroose CM Theranostics; 2018; 8(10):2799-2813. PubMed ID: 29774076 [No Abstract] [Full Text] [Related]
11. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers. Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126 [TBL] [Abstract][Full Text] [Related]
12. Enhanced CRISPR/Cas9-mediated biallelic genome targeting with dual surrogate reporter-integrated donors. Wu Y; Xu K; Ren C; Li X; Lv H; Han F; Wei Z; Wang X; Zhang Z FEBS Lett; 2017 Mar; 591(6):903-913. PubMed ID: 28214366 [TBL] [Abstract][Full Text] [Related]
13. Efficiency and Specificity of Targeted Integration Mediated by the Adeno-Associated Virus Serotype 2 Rep 78 Protein. Li P; Marino MP; Zou J; Argaw T; Morreale MT; Iaffaldano BJ; Reiser J Hum Gene Ther Methods; 2018 Jun; 29(3):135-145. PubMed ID: 29860898 [TBL] [Abstract][Full Text] [Related]
14. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system. Bevacqua RJ; Fernandez-Martín R; Savy V; Canel NG; Gismondi MI; Kues WA; Carlson DF; Fahrenkrug SC; Niemann H; Taboga OA; Ferraris S; Salamone DF Theriogenology; 2016 Nov; 86(8):1886-1896.e1. PubMed ID: 27566851 [TBL] [Abstract][Full Text] [Related]
15. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing. Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822 [TBL] [Abstract][Full Text] [Related]
16. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase. Li K; Cai D; Wang Z; He Z; Chen S Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178 [No Abstract] [Full Text] [Related]
17. Elimination of the cryptic plasmid in Leuconostoc citreum by CRISPR/Cas9 system. Jang YJ; Seo SO; Kim SA; Li L; Kim TJ; Kim SC; Jin YS; Han NS J Biotechnol; 2017 Jun; 251():151-155. PubMed ID: 28433723 [TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9; A robust technology for producing genetically engineered plants. Farooq R; Hussain K; Nazir S; Javed MR; Masood N Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631 [TBL] [Abstract][Full Text] [Related]
19. Generation of Cashmere Goats Carrying an Hao F; Yan W; Li X; Wang H; Wang Y; Hu X; Liu X; Liang H; Liu D Int J Biol Sci; 2018; 14(4):427-436. PubMed ID: 29725264 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the "safe harbor" AAVS1 locus. Castaño J; Bueno C; Jiménez-Delgado S; Roca-Ho H; Fraga MF; Fernandez AF; Nakanishi M; Torres-Ruiz R; Rodríguez-Perales S; Menéndez P Stem Cell Res; 2017 May; 21():137-140. PubMed ID: 28677529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]